Chad Swiatecki Staff Writer- Austin Business Journal Email | Twitter Vermillion Inc. on Thursday posted a loss of $4.2 million in the first quarter, or 11 cents per share, on revenue of $305,000, compared to a loss of $2.6 million, or 17 cents per share, on revenue of $328,000 in the year-earlier period. That revenue was derived from Vermillion’s partnership with Quest Diagnostics, which has been the sole marketing channel for the company’s OVA1 test for ovarian cancer. The company is ending its current partnership with Quest, though it will likely continue to do business with the diagnostics giant, and is developing new sales channels including the recently opened Aspira Labs...
↧